Figure 2.
Participant flow. *One patient restarted ITI treatment and one developed inhibitors during the extension phase: both patients rejoined the extension phase. ITI, immune tolerance induction
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.